Used primarily in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds. Its structure supports the development of central nervous system agents, particularly serotonin and dopamine receptor modulators. The compound’s trifluoromethyl group enhances metabolic stability and lipophilicity, making it valuable in optimizing drug candidates for improved brain penetration. It is also employed in the preparation of selective enzyme inhibitors and has been explored in the context of antipsychotic and antidepressant drug design. Due to its piperidine-benzotriazole framework, it serves as a scaffold in medicinal chemistry for structure-activity relationship studies.